Year |
Citation |
Score |
2017 |
Patel A, Li TW, Anreddy N, Wang DS, Sodani K, Gadhia S, Kathawala R, Yang DH, Cheng C, Chen ZS. Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport. Pharmacological Research. PMID 28455266 DOI: 10.1016/J.Phrs.2017.04.025 |
0.858 |
|
2017 |
Zhang H, Patel AS, Wang YJ, Zhang YK, Kathawala RJ, Qiu LH, Patel BA, Huang LH, Shukla S, Yang DH, Ambudkar SV, Fu L, Chen ZS. The BTK Inhibitor, Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1 and ABCC10 Overexpressing Cells and Tumors. Molecular Cancer Therapeutics. PMID 28265007 DOI: 10.1158/1535-7163.Mct-16-0511 |
0.804 |
|
2015 |
Anreddy N, Patel A, Zhang YK, Wang YJ, Shukla S, Kathawala RJ, Kumar P, Gupta P, Ambudkar SV, Wurpel JN, Chen ZS, Guo H. A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo. Oncotarget. PMID 26515463 DOI: 10.18632/Oncotarget.5747 |
0.807 |
|
2015 |
Singha B, Gatla HR, Phyo S, Patel A, Chen ZS, Vancurova I. IKK inhibition increases bortezomib effectiveness in ovarian cancer. Oncotarget. 6: 26347-58. PMID 26267322 DOI: 10.18632/Oncotarget.4713 |
0.587 |
|
2015 |
Katayama K, Kapoor K, Ohnuma S, Patel A, Swaim W, Ambudkar IS, Ambudkar SV. Revealing the fate of cell surface human P-glycoprotein (ABCB1): The Lysosomal Degradation Pathway. Biochimica Et Biophysica Acta. PMID 26057472 DOI: 10.1016/j.bbamcr.2015.06.001 |
0.384 |
|
2015 |
Wei L, Lu J, Xu H, Patel A, Chen ZS, Chen G. Silver nanoparticles: synthesis, properties, and therapeutic applications. Drug Discovery Today. 20: 595-601. PMID 25543008 DOI: 10.1016/J.Drudis.2014.11.014 |
0.478 |
|
2015 |
Kathawala RJ, Wei L, Anreddy N, Chen K, Patel A, Alqahtani S, Zhang YK, Wang YJ, Sodani K, Kaddoumi A, Ashby CR, Chen ZS. The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study. Oncotarget. 6: 510-21. PMID 25402202 DOI: 10.18632/Oncotarget.2638 |
0.855 |
|
2015 |
Anreddy N, Kumar P, Patel A, Zhang Y, Wang Y, Kathawala R, Wurpel JD, Chen Z. Abstract A01: A-803467, a sodium channel blocker, reverses ABCG2-mediated MDR in vitro as well as in vivo Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Pms14-A01 |
0.786 |
|
2015 |
Anreddy N, Patel A, Zhang Y, Wang Y, Shukla S, Kathawala RJ, Kumar P, Gupta P, Ambudkar SV, Wurpel JN, Chen Z. Abstract 4432: A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo Cancer Research. 75: 4432-4432. DOI: 10.1158/1538-7445.Am2015-4432 |
0.787 |
|
2014 |
Anreddy N, Patel A, Sodani K, Kathawala RJ, Chen EP, Wurpel JN, Chen ZS. PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR. Acta Pharmaceutica Sinica. B. 4: 202-207. PMID 26579384 DOI: 10.1016/J.Apsb.2014.02.003 |
0.812 |
|
2014 |
Anreddy N, Gupta P, Kathawala RJ, Patel A, Wurpel JN, Chen ZS. Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance. Molecules (Basel, Switzerland). 19: 13848-77. PMID 25191874 DOI: 10.3390/Molecules190913848 |
0.755 |
|
2014 |
Zhang H, Patel A, Ma SL, Li XJ, Zhang YK, Yang PQ, Kathawala RJ, Wang YJ, Anreddy N, Fu LW, Chen ZS. In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1. British Journal of Pharmacology. 171: 5845-57. PMID 25164592 DOI: 10.1111/Bph.12889 |
0.751 |
|
2014 |
Wang DS, Patel A, Shukla S, Zhang YK, Wang YJ, Kathawala RJ, Robey RW, Zhang L, Yang DH, Talele TT, Bates SE, Ambudkar SV, Xu RH, Chen ZS. Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2. Oncotarget. 5: 4529-42. PMID 24980828 DOI: 10.18632/Oncotarget.2102 |
0.801 |
|
2014 |
Wang DS, Patel A, Sim HM, Zhang YK, Wang YJ, Kathawala RJ, Zhang H, Talele TT, Ambudkar SV, Xu RH, Chen ZS. ARRY-334543 reverses multidrug resistance by antagonizing the activity of ATP-binding cassette subfamily G member 2. Journal of Cellular Biochemistry. 115: 1381-91. PMID 24939447 DOI: 10.1002/Jcb.24787 |
0.787 |
|
2014 |
Wang YJ, Kathawala RJ, Zhang YK, Patel A, Kumar P, Shukla S, Fung KL, Ambudkar SV, Talele TT, Chen ZS. Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1. Biochemical Pharmacology. 90: 367-78. PMID 24937702 DOI: 10.1016/J.Bcp.2014.06.006 |
0.817 |
|
2014 |
Zhang H, Zhang YK, Wang YJ, Kathawala RJ, Patel A, Zhu H, Sodani K, Talele TT, Ambudkar SV, Chen ZS, Fu LW. WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells. Cancer Science. 105: 1071-8. PMID 24903205 DOI: 10.1111/Cas.12462 |
0.842 |
|
2014 |
Zhang H, Wang YJ, Zhang YK, Wang DS, Kathawala RJ, Patel A, Talele TT, Chen ZS, Fu LW. AST1306, a potent EGFR inhibitor, antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance. Cancer Letters. 350: 61-8. PMID 24747122 DOI: 10.1016/J.Canlet.2014.04.008 |
0.738 |
|
2014 |
Zhang H, Kathawala RJ, Wang YJ, Zhang YK, Patel A, Shukla S, Robey RW, Talele TT, Ashby CR, Ambudkar SV, Bates SE, Fu LW, Chen ZS. Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10-mediated drug resistance. The International Journal of Biochemistry & Cell Biology. 51: 111-9. PMID 24726739 DOI: 10.1016/J.Biocel.2014.03.026 |
0.778 |
|
2014 |
Kathawala RJ, Chen JJ, Zhang YK, Wang YJ, Patel A, Wang DS, Talele TT, Ashby CR, Chen ZS. Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance. International Journal of Oncology. 44: 1634-42. PMID 24626598 DOI: 10.3892/Ijo.2014.2341 |
0.767 |
|
2014 |
Sodani K, Patel A, Anreddy N, Singh S, Yang DH, Kathawala RJ, Kumar P, Talele TT, Chen ZS. Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo. Biochemical Pharmacology. 89: 52-61. PMID 24565910 DOI: 10.1016/J.Bcp.2014.02.012 |
0.865 |
|
2014 |
Sun YL, Kumar P, Sodani K, Patel A, Pan Y, Baer MR, Chen ZS, Jiang WQ. Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells. Oncology Reports. 31: 1605-12. PMID 24481648 DOI: 10.3892/Or.2014.3002 |
0.873 |
|
2014 |
Kathawala RJ, Sodani K, Chen K, Patel A, Abuznait AH, Anreddy N, Sun YL, Kaddoumi A, Ashby CR, Chen ZS. Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study. Molecular Cancer Therapeutics. 13: 714-23. PMID 24431074 DOI: 10.1158/1535-7163.Mct-13-0743 |
0.859 |
|
2014 |
Yang D, Kathawala RJ, Chufan EE, Patel A, Ambudkar SV, Chen ZS, Chen X. Tivozanib reverses multidrug resistance mediated by ABCB1 (P-glycoprotein) and ABCG2 (BCRP). Future Oncology (London, England). 10: 1827-41. PMID 24295377 DOI: 10.2217/Fon.13.253 |
0.719 |
|
2014 |
Sodani K, Tiwari AK, Dai C, Abuznait AH, Patel A, Xiao Z, Ashby CR, Kaddoumi A, Fu L, Chen Z. Sildenafil Enhances the Anticancer Activity of Paclitaxel in an ABCB1-Mediated Multidrug Resistance Xenograft Mouse Model Journal of Cancer Research Updates. 3: 169-173. DOI: 10.6000/1929-2279.2014.03.03.7 |
0.855 |
|
2014 |
Kathawala R, Sodani K, Chen K, Patel A, Abuznait A, Anreddy N, Sun Y, Kaddoumi A, Ashby CR, Chen Z. Abstract 1964: Masitinib antagonizes ATP-binding cassette subfamily c member 10-mediated paclitaxel resistance: a preclinical study Cancer Research. 74: 1964-1964. DOI: 10.1158/1538-7445.Am2014-1964 |
0.866 |
|
2013 |
Chen JJ, Patel A, Sodani K, Xiao ZJ, Tiwari AK, Zhang DM, Li YJ, Yang DH, Ye WC, Chen SD, Chen ZS. bba, a synthetic derivative of 23-hydroxybutulinic acid, reverses multidrug resistance by inhibiting the efflux activity of MRP7 (ABCC10). Plos One. 8: e74573. PMID 24069321 DOI: 10.1371/Journal.Pone.0074573 |
0.842 |
|
2013 |
Patel A, Tiwari AK, Chufan EE, Sodani K, Anreddy N, Singh S, Ambudkar SV, Stephani R, Chen ZS. PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells. Cancer Chemotherapy and Pharmacology. 72: 189-99. PMID 23673445 DOI: 10.1007/S00280-013-2184-Z |
0.834 |
|
2013 |
Sun YL, Chen JJ, Kumar P, Chen K, Sodani K, Patel A, Chen YL, Chen SD, Jiang WQ, Chen ZS. Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar. Plos One. 8: e55576. PMID 23393594 DOI: 10.1371/Journal.Pone.0055576 |
0.853 |
|
2013 |
Tiwari AK, Sodani K, Dai CL, Abuznait AH, Singh S, Xiao ZJ, Patel A, Talele TT, Fu L, Kaddoumi A, Gallo JM, Chen ZS. Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models. Cancer Letters. 328: 307-17. PMID 23063650 DOI: 10.1016/J.Canlet.2012.10.001 |
0.838 |
|
2013 |
Wang D, Patel A, Kumar P, Xu R, Chen Z. Abstract B112: ARRY-334543 reverses multidrug resistance by antagonizing the activity of ATP-binding cassette subfamily G member 2. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-B112 |
0.773 |
|
2012 |
Kuang YH, Patel JP, Sodani K, Wu CP, Liao LQ, Patel A, Tiwari AK, Dai CL, Chen X, Fu LW, Ambudkar SV, Korlipara VL, Chen ZS. OSI-930 analogues as novel reversal agents for ABCG2-mediated multidrug resistance. Biochemical Pharmacology. 84: 766-74. PMID 22750060 DOI: 10.1016/J.Bcp.2012.06.019 |
0.846 |
|
2012 |
Sodani K, Tiwari AK, Singh S, Patel A, Xiao ZJ, Chen JJ, Sun YL, Talele TT, Chen ZS. GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance. Biochemical Pharmacology. 83: 1613-22. PMID 22414725 DOI: 10.1016/J.Bcp.2012.02.028 |
0.864 |
|
2012 |
Sun YL, Patel A, Kumar P, Chen ZS. Role of ABC transporters in cancer chemotherapy. Chinese Journal of Cancer. 31: 51-7. PMID 22257384 DOI: 10.5732/Cjc.011.10466 |
0.748 |
|
2012 |
Sodani K, Patel A, Kathawala RJ, Chen ZS. Multidrug resistance associated proteins in multidrug resistance. Chinese Journal of Cancer. 31: 58-72. PMID 22098952 DOI: 10.5732/Cjc.011.10329 |
0.845 |
|
2012 |
Sodani KS, Tiwari AK, Singh S, Patel A, Xiao Z, Chen J, Sun Y, Talele TT, Chen Z. Abstract 777: GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance Cancer Research. 72: 777-777. DOI: 10.1158/1538-7445.Am2012-777 |
0.855 |
|
2011 |
Shi Z, Tiwari AK, Patel AS, Fu LW, Chen ZS. Roles of sildenafil in enhancing drug sensitivity in cancer. Cancer Research. 71: 3735-8. PMID 21610107 DOI: 10.1158/0008-5472.CAN-11-0375 |
0.74 |
|
Show low-probability matches. |